Cardiac rupture, mortality and the timing of thrombolytic therapy: a meta-analysis.

Honan, M B; Harrell, F E; Reimer, K A; Califf, R M; Mark, D B; Pryor, D B; Hlatky, M A

Honan, M B; Harrell, F E; Reimer, K A; Califf, R M; Mark, D B; Pryor, D B; Hlatky, M A.

Affiliation

Honan MB; Department of Medicine, Duke University Medical Center, Durham, North Carolina.

J Am Coll Cardiol ; 16(2): 359-67, 1990 Aug.

Article in En | MEDLINE | ID: mdl-2142705

Subject(s)

Heart Rupture, Post-Infarction/mortality; Heart Rupture/mortality; Myocardial Infarction/drug therapy; Streptokinase/administration & dosage; Thrombolytic Therapy/methods; Drug Administration Schedule; Female; Heart Rupture, Post-Infarction/epidemiology; Heart Rupture, Post-Infarction/prevention & control; Humans; Incidence; Infusions, Intravenous; Male; Meta-Analysis as Topic; Randomized Controlled Trials as Topic; Regression Analysis; Risk Factors; Survival Rate

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Main subject: Streptokinase / Heart Rupture, Post-Infarction / Thrombolytic Therapy / Heart Rupture / Myocardial Infarction Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Incidence_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limits: Female / Humans / Male Language: En Journal: J Am Coll Cardiol Year: 1990 Type: Article

Search on Google

Add to My VHL

XML

PubMed Links